Download the report.
Life sciences executives are confronting a pivotal juncture in commercial strategy. The pharmaceutical and medical technology sectors in particular face a range of challenges in costs, pricing, regulations, and competition, as well in quickly evolving technology and market priorities for customer relationship management (CRM) models. A shakeout in the CRM market leaves life sciences companies with perhaps their most immediate concern and opportunity: reevaluating which CRM provider will best help them gain a competitive advantage, drive value, and transform the way they do business through the use of an agentic commercial model.
Explore HBR
HBR Store
About HBR
